Litcius/Paper detail

Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

Shuofeng Yuan, Xin Yin, Xiangzhi Meng, Jasper Fuk‐Woo Chan, Zi‐Wei Ye, Laura Riva, Lars Pache, Chris Chun-Yiu Chan, Pok-Man Lai, Chris Chung‐Sing Chan, Vincent Kwok‐Man Poon, Andrew Chak-Yiu Lee, Naoko Matsunaga, Yuan Pu, Chun‐Kit Yuen, Jianli Cao, Ronghui Liang, Kaiming Tang, Sheng Li, Yushen Du, Wan Xu, Chit-Ying Lau, Ko‐Yung Sit, Wing‐Kuk Au, Runming Wang, Yuyuan Zhang, Yan‐Dong Tang, Thomas Mandel Clausen, Jessica Pihl, Juntaek Oh, Kong‐Hung Sze, Jinxia Zhang, Hin Chu, Kin‐Hang Kok, Dong Wang, Xuehui Cai, Jeffrey D. Esko, Ivan Fan‐Ngai Hung, Ronald Adolphus Li, Honglin Chen, Hongzhe Sun, Dong‐Yan Jin, Ren Sun, Sumit K. Chanda, Kwok‐Yung Yuen

2021Nature211 citationsDOIOpen Access PDF

Topics & Concepts

ClofazimineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirologyCoronavirusBetacoronavirusSars virusCoronavirus InfectionsBiologyMedicineImmunologyInfectious disease (medical specialty)LeprosyOutbreakPathologyDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesTuberculosis Research and Epidemiology
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 | Litcius